Company intelligence / Profile preview

Arthur Cox

Ownership: Private
Employees: ~740
Development stage: Phase 2

Overview

Leading Irish law firm providing specialized legal services to life sciences/pharma/healthcare clients, including regulatory compliance, M&A, and product lifecycle management

Industry: Consulting

Drug pipeline

1 asset

nemvaleukin alfa

Phase 2

Indications: Mucosal melanoma, Platinum-resistant ovarian cancer

Partnerships

Irish Pharmaceutical Healthcare Association (IPHA)Irish MedTechEuropean Federation of Pharmaceutical Industries and Associations

Beyond the preview

Go deeper on Arthur Cox.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arthur Cox.

Explore the full profile